# Understanding and Maximizing the Community Impact of Antimalarial Treatment (INDIE-SMC)

> **NCT05878366** · NA · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 2978 (actual)

## Conditions studied

- Malaria
- Malaria,Falciparum

## Interventions

- **OTHER:** Seasonal Malaria Chemoprophylaxis (under 5 year old) implemented by the MoH without DOT
- **OTHER:** Seasonal Malaria Chemoprophylaxis (under 5 years old) with DOT
- **OTHER:** Seasonal Malaria Chemoprophylaxis (under 10 years old) with DOT

## Key facts

- **NCT ID:** NCT05878366
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-13
- **Primary completion:** 2024-01-15
- **Final completion:** 2024-03-30
- **Target enrollment:** 2978 (ACTUAL)
- **Last updated:** 2025-07-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05878366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05878366, "Understanding and Maximizing the Community Impact of Antimalarial Treatment (INDIE-SMC)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05878366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*